SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap's stock is surging as investors react to a Q3 earnings beat, a $500 million stock buyback, and a new $400 million AI partnership with Perplexity. The community is buzzing about the potential for a short squeeze and upgraded price targets, while also weighing concerns about profitability and the long-term sustainability of the rally.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending as investors anticipate upcoming earnings results, with many in the community expecting strong numbers driven by growth and the Alani Nu acquisition. Despite overall market uncertainty, the community expresses long-term confidence in CELH's execution and potential, while also closely monitoring potential short-term volatility and market manipulation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors anticipate Phase 3 data for their DMD treatment, deramiocel, expected mid-Q4, with the community actively discussing potential FDA approval pathways. Discussions also involve the StealthX exosome platform and recent job postings at Capricor and NS Pharma, hinting at possible positive outcomes. Community members are closely monitoring short interest and options activity, speculating on potential market reactions following the data release.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess the semiconductor sector's near-term trajectory amidst AI optimism and US-China trade concerns. Community discussions include reactions to earnings reports from key semiconductor companies and speculation about upcoming economic data releases and Federal Reserve actions. Bullish sentiment persists, while some are wary of overvaluation and the potential for a pullback.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amid speculation about potential partnerships or a buyout, with an earlier earnings call fueling anticipation. Community members are debating the likelihood of a deal, with some eyeing AstraZeneca as a possible partner, while others express skepticism and frustration with management. Bullish sentiment is building as some traders position for a potential breakout and short squeeze ahead of earnings.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation about a potential acquisition, with the community closely watching for a deal announcement, especially with earnings on the horizon.  Executive share selling and potential offers are hot topics.  The stock's valuation and possible bidding war dynamics are also being heavily debated by investors.

Caledonia Mining Corp. Plc engages in the exploration, development, and production of gold and other precious metals from its mineral properties. Its projects include Blanket Gold Mine and Maligreen. The company was founded on February 5, 1992 and is headquartered in St. Helier, the United Kingdom.

Caledonia Mining Corporation Plc

Caledonia Mining Corporation ($CMCL) is trending due to upcoming earnings and discussions around its potential growth, particularly the Bilboes project which could significantly increase production; the earnings are scheduled to be released Monday before the market opens. Community members are weighing the company's profitability against the political risks of operating in Zimbabwe, with some anticipating a positive impact from rising gold prices and others concerned about potential dilution from financing activities. Recent discussions also touch on the stock's valuation relative to its growth potential and comparison to other gold miners.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending as community members discuss its tokenomics, specifically the locked dev tokens until February and scheduled buybacks, which some believe will naturally increase the coin price.  Concerns about competitors potentially suppressing the token's price and calls for fair play are also circulating.  Traders are actively watching key price levels and anticipating potential volatility, with some suggesting it's time for a rebound.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

DVAX is trending due to a new $100 million share buyback program and updates regarding a partnership with VXRT for a novel oral COVID-19 vaccine. The community is discussing the potential financial benefits and strategic implications of this agreement, as well as concerns about delays in the FDA study protocol for HLAD in adults on hemodialysis. Investors are also weighing in on the impact of Deep Track's involvement and management's capital allocation decisions.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community discusses its potential for future growth and staking opportunities. Many users are accumulating and staking $SWEAT, motivated by the project's concept of earning crypto through walking and its potential for long-term gains. The conversation also highlights anticipation for increased utility and adoption of the Sweat Wallet in the US.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aehr Test Systems (AEHR) stock tumbled more than 20% in pre-market trading on Tuesday after the company reported weaker-than-expected second-quarter earnings.&nbsp;However, retail sentiment on Stocktwits showed improvement.The chip testing equipment manufacturer posted earnings of $0.02 per share, falling short of Wall Street's estimate of $0.03 per share, according to Koyfin.&nbsp;Quarterly revenue came in at $13.5 million, below the $15 million forecast, representing a steep 37% decline year-on-year (YoY).Despite the earnings miss, Aehr Test Systems reiterated its fiscal 2025 guidance, targeting at least $70 million in revenue and a non-GAAP net profit before taxes of at least 10%.&nbsp;The company highlighted key milestones achieved during the quarter, including securing its first AI processor customer for wafer-level burn-in and its first volume production orders for package part burn-in from an AI processor customer. It also landed its first gallium nitride (GaN) customer for high-volume production.Gallium has emerged as a critical material in advanced artificial intelligence (AI) technologies because of its superior electrical properties compared to silicon.As of&nbsp;Nov. 29, 2024, the company reported $35.2 million in cash and equivalents and an effective backlog of $26.6 million.<figure class="image"><a href="https://stocktwits.com/symbol/AEHR"><img style="aspect-ratio:1278/290;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_14_063500_fe2772ac2f.png" alt="Screenshot 2025-01-14 063500.png" width="1278" height="290"></a><figcaption>Aehr Test Systems Sentiment and Message Volume on Jan.14 as of 6:35 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment rose to ‘bullish’ from ‘neutral’ a day prior, with chatter levels surging to ‘extremely high’ from previously muted levels.Some users on the platform feel that the dip in share price is an opportunity to buy more shares.&nbsp;<stembedurl>https://stocktwits.com/MOOSEN/message/599911329</stembedurl><stembedurl>https://stocktwits.com/WallStreetBuyDip/message/599910492</stembedurl>Others believe the massive fall in stock price is an overreaction to earnings since the company has maintained its forward-looking guidance.&nbsp;<stembedurl>https://stocktwits.com/m4equals543/message/599909658</stembedurl><stembedurl>https://stocktwits.com/TheBullishTrade/message/599899550</stembedurl>Tuesday’s pre-market losses place <a href="https://stocktwits.com/symbol/AEHR">Aehr Test Systems’ stock</a> at its lowest level in over a month. The stock has dropped 7% over the last year, with most of the decline concentrated in January.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aehr-stock-dips-ahead-of-q2-earnings-investors-watch-recovery/chGNK3kRNF">Aehr Test Systems Stock Dips Ahead of Q2 Earnings As Retail Watches For Signs Of Recovery</a>

Aehr Stock Plummets Pre-Market On Q2 Earnings Miss, But Optimistic Guidance Bolsters Retail Faith

Despite the earnings miss, Aehr Test Systems reiterated its fiscal 2025 guidance, targeting at least $70 million in revenue and a non-GAAP net profit before taxes of at least 10%. 

Equity

Despite the earnings miss, Aehr Test Systems reiterated its fiscal 2025 guidance, targeting at least $70 million in revenue and a non-GAAP net profit before taxes of at least 10%. 


Aehr Test Systems (AEHR) stock fell over 3.5% in mid-day trading Monday ahead of its second-quarter earnings release scheduled after the bell.&nbsp;Analysts expect the chip maker to report earnings of $0.03 per share on revenue of $15.04 million, according to Stocktwits data.The company’s previous quarter saw a 36% decline in revenue to $12.1 million year-over-year and a 23% contraction in profit margins to 5%.&nbsp;Net income dropped sharply, down 86% to $660,000.The company is known for providing test systems for burning-in and testing memory and logic integrated circuits. It designs, manufactures, and markets solutions tailored to ensure the performance and durability of logic and memory devices, sensors, and optical components.Some retail investors on Stocktwits expressed optimism that new contracts could improve this quarter’s performance.&nbsp;Last week, Aehr announced an initial production order from an unnamed top-tier automotive semiconductor supplier for its FOX-XP wafer-level test and burn-in system.&nbsp;This system, designed for gallium nitride power semiconductor devices, is set for immediate shipment.Options activity ahead of earnings is elevated, with volume 2.4 times the norm. Calls outnumber puts at a ratio of 2:1, while implied volatility points to an anticipated price swing of approximately 16.2%, or $2.52, after the results.&nbsp;This is slightly below the median earnings move of 17.5% observed over the past eight quarters, suggesting relatively muted expectations.<figure class="image"><img style="aspect-ratio:1290/295;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_13_133932_395239628c.png" alt="Screenshot 2025-01-13 133932.png" width="1290" height="295"><figcaption>Aehr Test Systems Sentiment and Message Volume on Jan.13 as of 1:45 p.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment remained in the ‘neutral’ zone even as chatter increased to ‘normal’ from ‘low’ levels, a day ago.&nbsp;Some users on the platform were puzzled by the pre-earnings dip, while others expect strong forward guidance to lift the stock post-earnings.<stembedurl>https://stocktwits.com/DeepValueMicros/message/599811894</stembedurl><stembedurl>https://stocktwits.com/NakedDayTrader4/message/599810729</stembedurl><stembedurl>https://stocktwits.com/10baggerPete/message/599720518</stembedurl>Aehr Test Systems’ stock has declined by over 8% in the past year. In January alone, it lost 6.5% of its value.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/edison-international-stock-dips-as-ceo-admits-uncertainty-amid-wildfire-liability/chGNW1iRNl">Edison International Stock Plunges As CEO Admits Uncertainty Amid Wildfire Liability Concerns: Retail Sentiment Hits Year-Low</a>

Representative image of a chip engineer taking wafer out from box. (Photo by sinology/Getty Images)

Aehr Test Systems Stock Dips Ahead of Q2 Earnings As Retail Watches For Signs Of Recovery

Retail sentiment on Stocktwits is mixed as Aehr Test Systems’ stock declined pre-earnings, despite optimism around new semiconductor contracts.

CBSE
Listed Funds Trust - Changebridge Capital Sustainable Equity ETF

Feed

News

Sentiment

Fundamentals

Info

Latest CBSE News

CBSEListed Funds Trust - Changebridge Capital Sustainable Equity ETF